Product Recalls in North Carolina

Product recalls affecting North Carolina — including food, drugs, consumer products, medical devices, and vehicles distributed to North Carolina. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,763 recalls have been distributed to North Carolina in the last 12 months.

54,363 total recalls
2,763 in last 12 months

Showing 1302113040 of 13,606 recalls

DrugMarch 4, 2013· CareFusion 213, LLC

Recalled Item: SEPP 70% Isopropanol (isopropyl alcohol) 70% v/v Recalled by CareFusion 213,...

The Issue: Labeling: Not Elsewhere Classified: This product is misbranded because the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 4, 2013· CareFusion 213, LLC

Recalled Item: Donor Prep Kit containing 1 FREPP (70% isopropyl alcohol) Recalled by...

The Issue: Labeling: Not Elsewhere Classified: This product is misbranded because the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2013· Physicians Total Care, Inc.

Recalled Item: Voltaren 1% Gel Recalled by Physicians Total Care, Inc. Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration Date; This recall is...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 27, 2013· Mutual Pharmaceutical Company, Inc.

Recalled Item: Fenofibric Acid Recalled by Mutual Pharmaceutical Company, Inc. Due to...

The Issue: Labeling: Incorrect instructions; an error in section 5.11 of the patient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 27, 2013· Baxter Healthcare Corp.

Recalled Item: 0.9% Sodium Chloride Injection Recalled by Baxter Healthcare Corp. Due to...

The Issue: Labeling Wrong Barcode; It may display wrong product code 0.9% Sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 27, 2013· Mutual Pharmaceutical Company, Inc.

Recalled Item: FIBRICOR (fenofibric acid) Tablets Recalled by Mutual Pharmaceutical...

The Issue: Labeling: Incorrect instructions; an error in section 5.11 of the patient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 27, 2013· Mutual Pharmaceutical Company, Inc.

Recalled Item: Fenofibric Acid Recalled by Mutual Pharmaceutical Company, Inc. Due to...

The Issue: Labeling: Incorrect instructions; an error in section 5.11 of the patient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 26, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets Recalled by Mylan Pharmaceuticals Inc. Due to...

The Issue: Tablets/Capsules Imprinted With Wrong ID: Pharmaceuticals are imprinted with...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 26, 2013· Hospira Inc.

Recalled Item: Diazepam Injection Recalled by Hospira Inc. Due to Lack of Assurance of...

The Issue: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 26, 2013· Hospira Inc.

Recalled Item: Furosemide Injection Recalled by Hospira Inc. Due to Lack of Assurance of...

The Issue: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 26, 2013· Hospira Inc.

Recalled Item: QUELICIN (succinylcholine chloride) Injection Recalled by Hospira Inc. Due...

The Issue: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 26, 2013· Hospira Inc.

Recalled Item: Sodium Acetate Injection Recalled by Hospira Inc. Due to Lack of Assurance...

The Issue: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 26, 2013· Teva Pharmaceuticals USA, Inc.

Recalled Item: Cefdinir for Oral Suspension Recalled by Teva Pharmaceuticals USA, Inc. Due...

The Issue: Defective Container: This recall is being carried out due to the potential...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 25, 2013· Hospira Inc.

Recalled Item: Propofol Injectable Emulsion Recalled by Hospira Inc. Due to Presence of...

The Issue: Presence of Particulate Matter: Visible particulate embedded in vials was...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 22, 2013· Lupin Pharmaceuticals Inc.

Recalled Item: Ethambutol Hydrochloride Tablets USP Recalled by Lupin Pharmaceuticals Inc....

The Issue: Failed Impurities/Degradation Specifications: This product is being recalled...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 19, 2013· Novartis Consumer Health

Recalled Item: Voltaren Gel (diclofenac sodium topical gel) 1% Recalled by Novartis...

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 19, 2013· Novartis Consumer Health

Recalled Item: Target Up & Up Recalled by Novartis Consumer Health Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 19, 2013· Novartis Consumer Health

Recalled Item: Novartis Lamisil AT Cream Recalled by Novartis Consumer Health Due to...

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 19, 2013· Novartis Consumer Health

Recalled Item: Novartis Lamisil AT Cream for Jock Itch (terbinafine hydrochloride 1%...

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 19, 2013· Novartis Consumer Health

Recalled Item: Lamisil AT Cream (terbinafine hydrochloride 1% antifungal) Recalled by...

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund